La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Antiparkinson Agents (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiparkinson Agents (administration & dosage) < Antiparkinson Agents (adverse effects) < Antiparkinson Agents (chemistry)  Facettes :

List of bibliographic references indexed by Antiparkinson Agents (adverse effects)

Number of relevant bibliographic references: 132.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000A37 (2014) Asha Kishore [Inde] ; Traian Popa [France] ; Ammu Balachandran [Inde] ; Shyambabu Chandran [Inde] ; Salini Pradeep [Inde] ; Febina Backer [Inde] ; Syam Krishnan [Inde] ; Sabine Meunier [France]Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients.
000A70 (2014) Michael Feyder [Suède] ; Erik Södersten [Suède, Danemark] ; Emanuela Santini [Suède] ; Vincent Vialou [États-Unis, France] ; Quincey C. Laplant [États-Unis] ; Emily L. Watts [États-Unis] ; Giada Spigolon [Suède] ; Klaus Hansen [Danemark] ; Jocelyne Caboche [France] ; Eric Nestler [États-Unis] ; Gilberto Fisone [Suède]A role for mitogen- and stress-activated kinase 1 in L-DOPA-induced dyskinesia and ΔFosB expression
000C35 (2013) François Tison [France] ; Laurence Nègre-Pagès ; Wassilios G. Meissner ; Sandrine Dupouy ; Qin Li ; Marie-Laure Thiolat ; Thibaud Thiollier ; Monique Galitzky ; Fabienne Ory-Magne ; Agathe Milhet ; Laurent Marquine ; Umberto Spampinato ; Olivier Rascol ; Erwan BezardSimvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.
000C44 (2013) M. Verdet [France] ; J. Nicolau ; R. Lefaucheur ; D. Maltête ; S. Derrey ; A. DaragonRecurrent bilateral metatarsal "stress-and-insufficiency" fractures in a levodopa-treated young woman with Parkinson's disease.
000C71 (2013) Laetitia Barbin [France] ; Christophe Leux ; Paul Sauleau ; Claire Meyniel ; Jean-Michel Nguyen ; Yann Pereon ; Philippe DamierNon-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
000C80 (2013) W M M. Schuepbach [France] ; J. Rau ; K. Knudsen ; J. Volkmann ; P. Krack ; L. Timmermann ; T D H Lbig ; H. Hesekamp ; S M Navarro ; N. Meier ; D. Falk ; M. Mehdorn ; S. Paschen ; M. Maarouf ; M T Barbe ; G R Fink ; A. Kupsch ; D. Gruber ; G-H Schneider ; E. Seigneuret ; A. Kistner ; P. Chaynes ; F. Ory-Magne ; C. Brefel Courbon ; J. Vesper ; A. Schnitzler ; L. Wojtecki ; J-L Houeto ; B. Bataille ; D. Maltête ; P. Damier ; S. Raoul ; F. Sixel-Doering ; D. Hellwig ; A. Gharabaghi ; R. Krüger ; M O Pinsker ; F. Amtage ; J-M Régis ; T. Witjas ; S. Thobois ; P. Mertens ; M. Kloss ; A. Hartmann ; W H Oertel ; B. Post ; H. Speelman ; Yves Agid [France] ; C. Schade-Brittinger ; G. DeuschlNeurostimulation for Parkinson's disease with early motor complications.
000C94 (2013) M U Ferraye [France] ; C. Ardouin ; E. Lhommée ; V. Fraix ; P. Krack ; S. Chabardès ; E. Seigneuret ; A-L Benabid ; P. Pollak ; B. DebûLevodopa-resistant freezing of gait and executive dysfunction in Parkinson's disease.
000D20 (2013) Hélène Pouclet [France] ; Pascal Derkinderen ; Thibaud LebouvierFoot dystonia heralding levodopa-induced dyskinesias in Parkinson disease.
000D27 (2013) François Viallet [France] ; Séverine Pitel ; Sylvie Lancrenon ; Olivier BlinEvaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease.
000D29 (2013) Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Anne Pavy-Le Traon ; Olivier RascolEmerging drugs for autonomic dysfunction in Parkinson's disease.
000D73 (2013) Erwan Bézard [République populaire de Chine] ; Ana Mu Oz ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo CartaAnti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia.
000D99 (2013) Caroline Moreau [France] ; Arnaud Delval [France] ; Vincent Tiffreau [France] ; Luc Defebvre [France] ; Kathy Dujardin [France] ; Alain Duhamel [France] ; Gregory Petyt [France] ; Claude Hossein-Foucher [France] ; David Blum [France] ; Bernard Sablonnière [France] ; Susanna Schraen [France] ; Delphine Allorge [France] ; Alain Destée [France] ; Régis Bordet [France] ; David Devos [France]Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
000E34 (2013) Santiago Perez-Lloret [Argentine] ; María Ver Nica Rey ; Pietro Lucca Ratti ; Olivier RascolRotigotine transdermal patch for the treatment of Parkinson’s Disease
001062 (2012) Eugénie Lhommée [France] ; Hélène Klinger ; Stéphane Thobois ; Emmanuelle Schmitt ; Claire Ardouin ; Amélie Bichon ; Andrea Kistner ; Valérie Fraix ; Jing Xie ; Magaly Aya Kombo ; Stephan Chabardès ; Eric Seigneuret ; Alim-Louis Benabid ; Patrick Mertens ; Gustavo Polo ; Sebastien Carnicella ; Jean-Louis Quesada ; Jean-Luc Bosson ; Emmanuel Broussolle ; Pierre Pollak ; Paul KrackSubthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
001089 (2012) O. Rascol [France] ; J. Bronzova ; R A Hauser ; A E Lang ; C. Sampaio ; A. Theeuwes ; S V Van De WittePardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial.
001154 (2012) Santiago Perez-Lloret [France] ; María Ver Nica Rey ; Nelly Fabre ; Fabienne Ory ; Umberto Spampinato ; Jean-Louis Montastruc ; Olivier RascolDo Parkinson's disease patients disclose their adverse events spontaneously?
001164 (2012) Sylvia Navailles [France] ; Philippe De DeurwaerdèreContribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.
001325 (2012) Olivier Rascol [France] ; Joaquim Ferreira [Portugal] ; Laurence Nègre-Pages [France] ; Santiago Perez-Lloret [France] ; Lucette Lacomblez [France] ; Monique Galitzky [France] ; Jean-Christophe Lemarié [France] ; Jean-Christophe Corvol [France] ; Jonathan M. Brotchie [Canada] ; Laura Bossi [France]A proof‐of‐concept, randomized, placebo‐controlled, multiple cross‐overs (n‐of‐1) study of naftazone in Parkinson’s disease
001389 (2012) P. De Deurwaerdere [France] ; S. Navailles [France]What can we expect from the serotonergic side of L-DOPA?
001513 (2011) Christophe Baillard [France] ; Yvonnick Blanloeil ; Inanna Gabriel ; Eliane Melon ; Bertrand Rozec ; Jean-Christophe Rigal[Perioperative management of chronic treatment and medical devices. Neurological and psychiatric diseases].
001723 (2011) O. Rascol [France]Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents (adverse effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiparkinson Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (adverse effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024